167 senior director jobs found

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai’s human health care (hhc) mission. We’re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer’s disease. As we continue to expand, we are seeking highly-motivated individuals who want to work in a fast-paced environment and make a difference.  If this is your profile, we want to hear from you. Eisai is an equal opportunity employer and as such, is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity,...

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Established in 2006 by the merger of two 100-year-old Japanese pharmaceutical companies, Daiichi Sankyo, Inc. is headquartered in New Jersey. The organization includes U.S. commercial operations and global drug development. We offer a unique blend of an entrepreneurial environment and a collaborative culture, and the innovation that propels us forward comes from all corners of our company. At Daiichi Sankyo, good ideas don't just happen in the lab, but also in conference rooms, at desks and in the field, contributed both by individuals and groups.

Established in 2006 by the merger of two 100-year-old Japanese pharmaceutical companies, Daiichi Sankyo, Inc. is headquartered in New Jersey. The organization includes U.S. commercial operations and global drug development. We offer a unique blend of an entrepreneurial environment and a collaborative culture, and the innovation that propels us forward comes from all corners of our company. At Daiichi Sankyo, good ideas don't just happen in the lab, but also in conference rooms, at desks and in the field, contributed both by individuals and groups.

Established in 2006 by the merger of two 100-year-old Japanese pharmaceutical companies, Daiichi Sankyo, Inc. is headquartered in New Jersey. The organization includes U.S. commercial operations and global drug development. We offer a unique blend of an entrepreneurial environment and a collaborative culture, and the innovation that propels us forward comes from all corners of our company. At Daiichi Sankyo, good ideas don't just happen in the lab, but also in conference rooms, at desks and in the field, contributed both by individuals and groups.

Established in 2006 by the merger of two 100-year-old Japanese pharmaceutical companies, Daiichi Sankyo, Inc. is headquartered in New Jersey. The organization includes U.S. commercial operations and global drug development. We offer a unique blend of an entrepreneurial environment and a collaborative culture, and the innovation that propels us forward comes from all corners of our company. At Daiichi Sankyo, good ideas don't just happen in the lab, but also in conference rooms, at desks and in the field, contributed both by individuals and groups.

As a leader in plasma collection, CSL Plasma is committed to excellence and innovation in everything we do. Our work helps to ensure that tens of thousands of people are able to live normal, healthy lives. We are committed to our work because lives depend on us. CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 270 plasma collection centers in U.S., Europe and China and employs over 12,000 employees. CSL Plasma is vertically integrated, meaning plasma collected at CSL Plasma facilities is used by CSL Behring for the sole purpose of manufacturing and delivering its life-saving therapies to people in more than 70 countries. CSL Plasma is a subsidiary of CSL Behring, a global biotech leader and a member of the CSL Group of companies. The parent company, CSL Limited (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia.

As a leader in plasma collection, CSL Plasma is committed to excellence and innovation in everything we do. Our work helps to ensure that tens of thousands of people are able to live normal, healthy lives. We are committed to our work because lives depend on us. CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 270 plasma collection centers in U.S., Europe and China and employs over 12,000 employees. CSL Plasma is vertically integrated, meaning plasma collected at CSL Plasma facilities is used by CSL Behring for the sole purpose of manufacturing and delivering its life-saving therapies to people in more than 70 countries. CSL Plasma is a subsidiary of CSL Behring, a global biotech leader and a member of the CSL Group of companies. The parent company, CSL Limited (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia.

As a leader in plasma collection, CSL Plasma is committed to excellence and innovation in everything we do. Our work helps to ensure that tens of thousands of people are able to live normal, healthy lives. We are committed to our work because lives depend on us. CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 270 plasma collection centers in U.S., Europe and China and employs over 12,000 employees. CSL Plasma is vertically integrated, meaning plasma collected at CSL Plasma facilities is used by CSL Behring for the sole purpose of manufacturing and delivering its life-saving therapies to people in more than 70 countries. CSL Plasma is a subsidiary of CSL Behring, a global biotech leader and a member of the CSL Group of companies. The parent company, CSL Limited (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia.

Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world.

Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world.

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

Bristol Myers Squibb is a global biopharmaceutical company committed to creating innovative medicines for millions of patients around the world fighting serious diseases in therapeutic areas such as oncology, hematology, immunology, cardiovascular and neuroscience. At the same time, we also nurture our own team with inspiring work and challenging career options.

Bristol Myers Squibb is a global biopharmaceutical company committed to creating innovative medicines for millions of patients around the world fighting serious diseases in therapeutic areas such as oncology, hematology, immunology, cardiovascular and neuroscience. At the same time, we also nurture our own team with inspiring work and challenging career options.

We came to Biogen to make an impact, to transform rigorous science into first-in-class medicines. We stay to create new possibilities together. We strive for excellence and go beyond the expected because we care deeply about making a difference for the many people we serve.

We came to Biogen to make an impact, to transform rigorous science into first-in-class medicines. We stay to create new possibilities together. We strive for excellence and go beyond the expected because we care deeply about making a difference for the many people we serve.

We came to Biogen to make an impact, to transform rigorous science into first-in-class medicines. We stay to create new possibilities together. We strive for excellence and go beyond the expected because we care deeply about making a difference for the many people we serve.